Literature DB >> 73696

Insulin rather than glucose homoeostasis in the pathophysiology of diabetes.

R C Turner, R R Holman.   

Abstract

Hepatic glucose efflux is very sensitive to changes in plasma-insulin and it is postulated that this provides an important feedback control of insulin secretion. In diabetes this hepatic "insulin sensor" increases the basal plasma-glucose until the impaired beta cells are sufficiently stimulated to secrete normal basal insulin concentrations. Glucose regulation thus becomes of secondary importance to the maintenance of basal insulin secretion, which is teleologically needed for the "anabolic" requirements of cell growth. This hypothesis provides an explanation for the "normal" basal plasma-insulin concentrations found in diabetes in spite of impaired beta-cell function. This maintenance of basal insulin secretion accounts for the discrepancy between the marked hyperglycaemia and minimal ketosis of maturity onset diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 73696     DOI: 10.1016/s0140-6736(76)91739-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?

Authors:  K Faerch; C Brøns; A C Alibegovic; A Vaag
Journal:  J Physiol       Date:  2010-01-25       Impact factor: 5.182

2.  Duplication of the blood glucose curve of an OGTT in dogs by a prospectively programmed I.V. infusion: infusion pattern and IRI response.

Authors:  U Fischer; E J Freyse; E Salzsieder; G Albrecht
Journal:  Acta Diabetol Lat       Date:  1978 Sep-Dec

Review 3.  Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.

Authors:  Bo Ahrén; James E Foley
Journal:  Diabetologia       Date:  2016-02-19       Impact factor: 10.122

4.  Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.

Authors:  S H Jacobsen; S C Olesen; C Dirksen; N B Jørgensen; K N Bojsen-Møller; U Kielgast; D Worm; T Almdal; L S Naver; L E Hvolris; J F Rehfeld; B S Wulff; T R Clausen; D L Hansen; J J Holst; S Madsbad
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

5.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Insulin resistance and gray matter volume in neurodegenerative disease.

Authors:  J K Morris; E D Vidoni; R D Perea; R Rada; D K Johnson; K Lyons; R Pahwa; J M Burns; R A Honea
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

7.  Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

Authors:  J P Hosker; M A Burnett; E G Davies; E A Harris; R C Turner
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

8.  Glucose control of basal insulin secretion in diabetes.

Authors:  S T McCarthy; E Harris; R C Turner
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

9.  Impact of common variation in bone-related genes on type 2 diabetes and related traits.

Authors:  Liana K Billings; Yi-Hsiang Hsu; Rachel J Ackerman; Josée Dupuis; Benjamin F Voight; Laura J Rasmussen-Torvik; Serge Hercberg; Mark Lathrop; Daniel Barnes; Claudia Langenberg; Jennie Hui; Mao Fu; Nabila Bouatia-Naji; Cecile Lecoeur; Ping An; Patrik K Magnusson; Ida Surakka; Samuli Ripatti; Lene Christiansen; Christine Dalgård; Lasse Folkersen; Elin Grundberg; Per Eriksson; Jaakko Kaprio; Kirsten Ohm Kyvik; Nancy L Pedersen; Ingrid B Borecki; Michael A Province; Beverley Balkau; Philippe Froguel; Alan R Shuldiner; Lyle J Palmer; Nick Wareham; Pierre Meneton; Toby Johnson; James S Pankow; David Karasik; James B Meigs; Douglas P Kiel; Jose C Florez
Journal:  Diabetes       Date:  2012-06-14       Impact factor: 9.337

10.  Determinants and consequences of insulin initiation for type 2 diabetes in France: analysis of the National Health and Wellness Survey.

Authors:  Gérard Reach; Véronique Le Pautremat; Shaloo Gupta
Journal:  Patient Prefer Adherence       Date:  2013-10-04       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.